These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12911945)

  • 21. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant activated factor VII for the treatment of life-threatening haemorrhage.
    Eikelboom JW; Bird R; Blythe D; Coyle L; Gan E; Harvey M; Isbister J; Leahy M; McIlroy D; Rahimpanah F; Ramanthan S; Strasser S; Ward C; Watts A; Towler S; Yi Q
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):713-7. PubMed ID: 14614349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
    Baudo F; de Cataldo F; Gaidano G;
    Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
    Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
    J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
    Schneiderman J; Nugent DJ; Young G
    Haemophilia; 2004 Jul; 10(4):347-51. PubMed ID: 15230948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review.
    Franchini M; Veneri D; Lippi G
    Bone Marrow Transplant; 2007 Jun; 39(12):729-35. PubMed ID: 17417659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
    Zver S; Andoljsek D; Cernelc P
    Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
    Kessler C
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia.
    Osborne W; Bhandari S; Tait RC; Franklin IM
    Clin Lab Haematol; 2004 Jun; 26(3):229-31. PubMed ID: 15163323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor VIIa and the surgical patient.
    Scarpelini S; Rizoli S
    Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
    Morfini M; Auerswald G; Kobelt RA; Rivolta GF; Rodriguez-Martorell J; Scaraggi FA; Altisent C; Blatny J; Borel-Derlon A; Rossi V
    Haemophilia; 2007 Sep; 13(5):502-7. PubMed ID: 17880436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
    Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
    Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ongoing NovoSeven trials.
    Erhardtsen E
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant factor VIIa in major abdominal surgery and liver transplantation.
    da Silva Viana J
    Transplant Proc; 2006 Apr; 38(3):818-9. PubMed ID: 16647481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U
    Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.